Catalog No.:AA01SOO8

1239729-06-6 | 2H-1,4-Benzoxazin-3(4H)-one, 6-[4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy]-

Name: Name:2H-1,4-Benzoxazin-3(4H)-one, 6-[4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy]-
Brand: AABLOCKS
SKU: AA01SOO8
Availability: InStock
Rating: 90 (10 reviews)

Pack Size

Purity

Availability

Price(USD)

Quantity

1mg

95%

1 week

$208.00 $146.00

- +

5mg

95%

1 week

$432.00 $303.00

- +

10mg

95%

1 week

$701.00 $491.00

- +

25mg

95%

1 week

$1,076.00 $753.00

- +

50mg

95%

1 week

$1,463.00 $1,024.00

- +

100mg

95%

1 week

$1,966.00 $1,376.00

- +

500mg

95%

1 week

$3,886.00 $2,720.00

- +

Technical Information
Properties
Literature
Request for Quotation
Download SDS

Technical Information
Properties
Literature

Technical Information

Catalog Number:

AA01SOO8

Chemical Name:

2H-1,4-Benzoxazin-3(4H)-one, 6-[4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy]-

CAS Number:

1239729-06-6

Molecular Formula:

C22H25Cl2N3O3

Molecular Weight:

450.3582

SMILES:

O=C1COc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl

Properties

Literature

Title: Reviva Pharmaceuticals Reports RP5063 Positive Efficacy Results for Memory Deficits

Title: Bhat L, et al. Evaluation of the effects of RP5063, a novel, multimodal, serotonin receptor modulator, as single-agent therapy and co-administrated with sildenafil, bosentan, and treprostinil in a monocrotaline-induced pulmonary arterial hypertension rat model.Eur J Pharmacol. 2018 May 15;827:159-166.

Title: L. Bhat,et al. Rp5063 Prevents Monocrotaline Induced Pulmonary Arterial Hypertension In Rats.

Quotation Request

Company Name:

Contact Person:

Email:

Quantity Required:

Country:

Additional Info:

SDS